
    
      Primary Outcome:

      The primary statistical hypothesis to be assessed in this study is whether the mean C-peptide
      value for study subjects receiving GABA differs significantly from the mean value for placebo
      subjects assessed at follow-up.

      Secondary Outcome:

      The study will examine the HbA1C and the daily dosage of insulin (units/kg).

      Exploratory Endpoint:

      The study will assess the effects of treatment on inflammatory markers and immunological
      outcomes.

      Major Inclusion Criteria:

      Type 1 diabetes within past 6 months Age 5-21 years* At least one diabetes associated
      autoantibody
    
  